FARMINGTON HILLS, Mich., June 13, 2018 /PRNewswire-PRWeb/ -- E.M.M.A. International Consulting Group, Inc. (EMMA International),
With a wide range of skills and experiences as leaders in their fields, the members of the Advisory Board will work closely with the firm's leadership team to address the growing needs of the market place, and plan for future strategic and regional growth.
The Advisory Board members are:
"I am delighted to work with such an accomplished group of seasoned professionals. EMMA International is grateful for their support, input and expertise to enable us to keep our finger on the pulse of the industry, said Dr. Carmine Jabri, President/CEO of EMMA International. The insight, contribution, and involvement of the Advisory Board will prove to be invaluable to the firm, its leadership team, and all stakeholders involved. The members of the Advisory Board, through their expertise, accomplishments, and astounding reputation, will help EMMA International in its current and future strategic direction."
To learn more about EMMA International's Advisory Board click here.
About EMMA International
E.M.M.A. International Consulting Group, Inc. is a global leader in management consulting services, with headquarters in Farmington Hills, MI, as well as offices in Florida, Pennsylvania, and Lebanon (MENA). We focus on quality, regulatory, and compliance services for the biotechnology, pharmaceuticals, and medical device industries. EMMA International has services available to satisfy all your quality and compliance needs. We exclusively offer QualiPro, an EQMS, through our partnership with Saphir Consult.
For more information, visit http://www.emmainternational.com/
If you would like additional information, please contact Kira Jabri, VP/COO at 248-987-4497 or email at email@example.com.
SOURCE Emma International Consulting Group
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All